AZD6738 specifically synergizes some PARP inhibitors in particular DNA repair-deficient cell lines, providing rationale for scrutinizing synergistic interactions between PARP and ATR inhibitors in immortalized or cancer cell lines that have defects in another HRR-associated gene. The gene discussed is ATR; the disease is cancer.